Open Actively Recruiting

Exploration into the association between DCN expression and MR phenotypes in GBM "Molecular MR-PET to characterize malignant transformation and identify therapeutic vulnerabilities in human IDH-mutant gliomas" NIH F30 CA284809

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Phase
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
21-002112
Category
Brain Cancer
Principal Investigator
Benjamin Ellingson
Location
  • UCLA Westwood